Other Capital Market Information | 1 July 2019 11:50
Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para.
1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052
01.07.2019 / 11:50
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
- Share buy-back - 2nd Interim Report
In the period from June 24, 2019 until and including June 28, 2019, a total
of 235,791 shares were repurchased within the framework of the share buy-
back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical
Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of
Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU)
2016/1052.
The purchase was carried out exclusively by a credit institution
commissioned by Fresenius Medical Care via the XETRA trading platform on
the Frankfurt Stock Exchange:
Day of repurchase Aggregated volume in Weighted average share
number of shares price
in EUR
24.06.2019 61,122 69.28600
25.06.2019 49,807 68.12725
26.06.2019 44,119 68.35652
27.06.2019 39,549 68.73629
28.06.2019 41,194 68,94388
The total volume of shares repurchased within the framework of this share
buy-back in the period from June 17, 2019 until and including June 28, 2019
therefore amounts to 504,672 shares.
Detailed information on the transactions pursuant to Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical
Care's website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board
Bad Homburg v.d.H., July 1, 2019
---------------------------------------------------------------------------
01.07.2019 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com
End of News DGAP News Service